Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the US in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
140 companies reporting in the next 90 days. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Thursday, Aug 27 · Earnings today · 1 company | |||||
| HQY | HealthEquity, Inc. | Healthcare | $8.75B | +3.14% | |
| Tuesday, Sep 1 · in 5 days · 1 company | |||||
| MMED | MiniMed Group, Inc. | Healthcare | $5.48B | +10.49% | |
| Thursday, Oct 8 · in 42 days · 2 companies | |||||
| NRIX | Nurix Therapeutics, Inc. | Healthcare | $2.77B | +10.60% | |
| NEOG | Neogen Corporation | Healthcare | $2.54B | +27.31% | |
| Tuesday, Oct 27 · in 61 days · 6 companies | |||||
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| Chemed Corporation |
| Healthcare |
| $7.11B |
| +5.98% |
| RCUS | Arcus Biosciences, Inc. | Healthcare | $3.92B | +13.72% |
| ARQT | Arcutis Biotherapeutics, Inc. | Healthcare | $3.12B | −11.54% |
| WGS | GeneDx Holdings Corp. | Healthcare | $2.69B | +45.90% |
| ATRC | AtriCure, Inc. | Healthcare | $2.45B | +21.18% |
| NEO | NeoGenomics, Inc. | Healthcare | $2.26B | +29.63% |
| Wednesday, Oct 28 · in 62 days · 5 companies | |||||
| AVTR | Avantor, Inc. | Healthcare | $9.81B | +16.75% | |
| WAY | Waystar Holding Corp. | Healthcare | $4.63B | +2.03% | |
| NVST | Envista Holdings Corporation | Healthcare | $4.47B | +3.12% | |
| VKTX | Viking Therapeutics, Inc. | Healthcare | $4.01B | +1.54% | |
| AXGN | AxoGen, Inc. Common Stock | Healthcare | $2.68B | +25.35% | |
| Thursday, Oct 29 · in 63 days · 11 companies | |||||
| ATR | AptarGroup, Inc. | Healthcare | $8.60B | −1.52% | |
| AMRX | Amneal Pharmaceuticals, Inc. | Healthcare | $6.27B | −4.10% | |
| TVTX | Travere Therapeutics, Inc. | Healthcare | $6.24B | +20.05% | |
| TFX | Teleflex Incorporated | Healthcare | $5.88B | +3.38% | |
| MMSI | Merit Medical Systems, Inc. | Healthcare | $5.44B | +15.65% | |
| ITGR | Integer Holdings Corporation | Healthcare | $4.25B | +24.72% | |
| OPCH | Option Care Health, Inc. | Healthcare | $3.60B | +6.94% | |
| TMDX | TransMedics Group, Inc. | Healthcare | $3.19B | +20.88% | |
| ALHC | Alignment Healthcare, Inc. | Healthcare | $2.88B | −24.58% | |
| KLRA | Kailera Therapeutics, Inc. | Healthcare | $2.39B | +10.16% | |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | Healthcare | $2.03B | −5.56% | |
| Friday, Oct 30 · in 64 days · 1 company | |||||
| BFLY | Butterfly Network, Inc. | Healthcare | $2.30B | +20.50% | |
| Monday, Nov 2 · in 67 days · 6 companies | |||||
| TGTX | TG Therapeutics, Inc. Common Stock | Healthcare | $8.42B | +0.29% | |
| BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | $2.51B | +0.92% | |
| NUVB | Nuvation Bio Inc. | Healthcare | $2.44B | +4.04% | |
| UFPT | UFP Technologies, Inc. | Healthcare | $2.36B | +18.02% | |
| ADUS | Addus HomeCare Corporation | Healthcare | $2.25B | +1.25% | |
| MD | Pediatrix Medical Group, Inc. | Healthcare | $2.19B | +0.34% | |
| Tuesday, Nov 3 · in 68 days · 15 companies | |||||
| PCVX | Vaxcyte, Inc. | Healthcare | $9.09B | +11.89% | |
| BRKR | Bruker Corporation | Healthcare | $8.69B | −9.30% | |
| SYRE | Spyre Therapeutics, Inc. | Healthcare | $8.13B | −6.36% | |
| RYTM | Rhythm Pharmaceuticals, Inc. | Healthcare | $7.78B | +3.54% | |
| HNGE | Hinge Health, Inc. | Healthcare | $7.25B | +20.27% | |
| COGT | Cogent Biosciences, Inc. | Healthcare | $6.39B | −9.71% | |
| LQDA | Liquidia Corporation | Healthcare | $6.31B | −17.81% | |
| SHC | Sotera Health Company | Healthcare | $5.58B | +10.02% | |
| VCYT | Veracyte, Inc. Common Stock | Healthcare | $3.56B | −20.41% | |
| BEAM | Beam Therapeutics Inc. | Healthcare | $3.21B | +14.83% | |
| CDNA | CareDx, Inc. | Healthcare | $2.64B | +42.55% | |
| SUPN | Supernus Pharmaceuticals, Inc. | Healthcare | $2.61B | −5.97% | |
| RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | $2.61B | +1.77% | |
| HRMY | Harmony Biosciences Holdings, Inc. | Healthcare | $2.31B | +10.88% | |
| STOK | Stoke Therapeutics, Inc. | Healthcare | $2.14B | +12.59% | |
| Wednesday, Nov 4 · in 69 days · 14 companies | |||||
| CAI | Caris Life Sciences, Inc. | Healthcare | $7.58B | +72.03% | |
| MIRM | Mirum Pharmaceuticals, Inc. | Healthcare | $5.98B | −12.22% | |
| ACAD | ACADIA Pharmaceuticals Inc. | Healthcare | $5.07B | +13.73% | |
| TNGX | Tango Therapeutics, Inc. | Healthcare | $4.29B | −4.43% | |
| ADPT | Adaptive Biotechnologies Corporation | Healthcare | $4.18B | +16.16% | |
| TARS | Tarsus Pharmaceuticals, Inc. | Healthcare | $3.10B | +19.85% | |
| ACHC | Acadia Healthcare Company, Inc. | Healthcare | $2.85B | −6.45% | |
| CURA.TO | Curaleaf Holdings, Inc. | Healthcare | $2.51B | +8.58% | |
| OCUL | Ocular Therapeutix, Inc. | Healthcare | $2.37B | +27.46% | |
| CLOV | Clover Health Investments, Corp. | Healthcare | $2.26B | −1.96% | |
| ADMA | ADMA Biologics, Inc. | Healthcare | $2.16B | +9.56% | |
| ESTA | Establishment Labs Holdings Inc. | Healthcare | $2.15B | −21.16% | |
| XNCR | Xencor, Inc. Common Stock | Healthcare | $2.11B | +42.41% | |
| SRPT | Sarepta Therapeutics, Inc. | Healthcare | $2.06B | +26.12% | |
| Thursday, Nov 5 · in 70 days · 38 companies | |||||
| PODD | Insulet Corporation | Healthcare | $9.94B | −14.38% | |
| PTGX | Protagonist Therapeutics, Inc. | Healthcare | $9.80B | +10.71% | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Healthcare | $9.00B | +1.17% | |
| TXG | 10x Genomics, Inc. | Healthcare | $8.37B | +36.58% | |
| LNTH | Lantheus Holdings, Inc. | Healthcare | $6.58B | −1.77% | |
| DNTH | Dianthus Therapeutics, Inc. | Healthcare | $6.13B | +9.01% | |
| PTCT | PTC Therapeutics, Inc. Common Stock | Healthcare | $6.07B | −3.58% | |
| RDNT | RadNet, Inc. | Healthcare | $6.05B | +20.96% | |
| DFTX | Definium Therapeutics, Inc. | Healthcare | $5.88B | +4.31% | |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | $5.74B | −2.85% | |
| DYN | Dyne Therapeutics, Inc. | Healthcare | $4.92B | +1.78% | |
| HAE | Haemonetics Corporation | Healthcare | $4.85B | +29.15% | |
| EWTX | Edgewise Therapeutics, Inc. | Healthcare | $4.80B | +9.99% | |
| LFST | LifeStance Health Group, Inc. | Healthcare | $4.69B | +8.10% | |
| BLLN | BillionToOne, Inc. | Healthcare | $4.54B | −28.00% | |
| ICUI | ICU Medical, Inc. | Healthcare | $4.49B | +8.33% | |
| CON | Concentra Group Holdings Parent, Inc. | Healthcare | $4.44B | +6.91% | |
| DOCS | Doximity, Inc. | Healthcare | $4.41B | +15.39% | |
| RLAY | Relay Therapeutics, Inc. | Healthcare | $4.26B | +6.40% | |
| INDV | Indivior Pharmaceuticals, Inc. | Healthcare | $4.23B | −12.60% | |
| AMLX | Amylyx Pharmaceuticals, Inc. | Healthcare | $4.13B | +89.67% | |
| IRTC | iRhythm Holdings, Inc. | Healthcare | $4.06B | +1.52% | |
| DNLI | Denali Therapeutics Inc. | Healthcare | $3.98B | +2.16% | |
| IOVA | Iovance Biotherapeutics, Inc. | Healthcare | $3.66B | +71.91% | |
| GPCR | Structure Therapeutics Inc. | Healthcare | $3.56B | +3.05% | |
| PLSE | Pulse Biosciences, Inc. | Healthcare | $3.43B | +35.61% | |
| IMNM | Immunome, Inc. | Healthcare | $3.34B | +23.82% | |
| MRVI | Maravai LifeSciences Holdings, Inc. | Healthcare | $3.30B | +29.74% | |
| MBX | MBX Biosciences, Inc. | Healthcare | $3.22B | +11.16% | |
| IRON | Disc Medicine, Inc. | Healthcare | $3.17B | +10.74% | |
| WRBY | Warby Parker Inc. | Healthcare | $3.15B | −2.00% | |
| AVAH | Aveanna Healthcare Holdings Inc. | Healthcare | $2.97B | +37.71% | |
| BKD | Brookdale Senior Living Inc. | Healthcare | $2.91B | −20.62% | |
| VRDN | Viridian Therapeutics, Inc. | Healthcare | $2.75B | +24.35% | |
| PRVA | Privia Health Group, Inc. | Healthcare | $2.71B | −15.14% | |
| VERA | Vera Therapeutics, Inc. | Healthcare | $2.65B | +10.50% | |
| RAPP | Rapport Therapeutics, Inc. | Healthcare | $2.52B | +25.12% | |
| PBH | Prestige Consumer Healthcare Inc. | Healthcare | $2.47B | +0.83% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.